176 related articles for article (PubMed ID: 9337201)
1. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
Pakala R; Willerson JT; Benedict CR
Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201
[TBL] [Abstract][Full Text] [Related]
2. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists.
Pakala R; Benedict CR
J Lab Clin Med; 1998 Jun; 131(6):527-37. PubMed ID: 9626988
[TBL] [Abstract][Full Text] [Related]
3. Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation.
Pakala R; Benedict C
J Lab Clin Med; 1999 Dec; 134(6):659-67. PubMed ID: 10595795
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation.
Pakala R
Cardiovasc Radiat Med; 2004; 5(1):20-6. PubMed ID: 15275628
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Atherosclerosis; 2001 Mar; 155(1):37-44. PubMed ID: 11223424
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.
Pakala R; Pakala R; Benedict C
Lipids; 1999 Sep; 34(9):915-20. PubMed ID: 10574655
[TBL] [Abstract][Full Text] [Related]
8. Angiopeptin, a somatostatin analogue, inhibits rat coronary artery and aorta smooth muscle cell proliferation induced by the thromboxane A2 mimetic U46619.
Zhao Y; Foegh ML
Prostaglandins; 1997 Nov; 54(5):781-93. PubMed ID: 9491208
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 potentiates thrombin-induced proliferation of coronary artery smooth muscle cells.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Adv Exp Med Biol; 1997; 433():387-90. PubMed ID: 9561177
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
Dorn GW; Becker MW; Davis MG
J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
Hanasaki K; Nakano T; Arita H
Biochem Pharmacol; 1990 Dec; 40(11):2535-42. PubMed ID: 2148480
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA.
Zucker TP; Bönisch D; Muck S; Weber AA; Bretschneider E; Glusa E; Schrör K
Circulation; 1998 Feb; 97(6):589-95. PubMed ID: 9494030
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid.
Pakala R; Pakala R; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 1999 Apr; 60(4):275-81. PubMed ID: 10397410
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
[TBL] [Abstract][Full Text] [Related]
15. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
Ogawa T; Sugidachi A; Asai F; Koike H
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
[TBL] [Abstract][Full Text] [Related]
16. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Vasc Res; 2001; 38(4):341-9. PubMed ID: 11455205
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Hypertens; 2001 Dec; 19(12):2191-6. PubMed ID: 11725163
[TBL] [Abstract][Full Text] [Related]
19. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
20. Dominant contribution of 5-hydroxytryptamine over thromboxane A2 in contractile response of rabbit isolated aortic preparation to thrombin activated platelets.
Nakanishi H; Matsuoka I; Ono T; Nakahata N
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):255-67. PubMed ID: 8747793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
